Literature DB >> 21943856

Carotid atherosclerosis in patients with untreated chronic obstructive pulmonary disease.

S J Kim1, D W Yoon, E J Lee, G Y Hur, K H Jung, S Y Lee, S Y Lee, C Shin, J J Shim, K H In, K H Kang, S H Yoo, J H Kim.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is associated with systemic inflammation.
OBJECTIVE: To evaluate carotid artery intima-media thickness (IMT), high sensitivity C-reactive protein (hsCRP) and their correlation in newly diagnosed untreated patients with COPD.
DESIGN: Post-bronchodilator spirometry, carotid artery IMT and blood tests were measured in patients with COPD (COPD group). Age, sex, body mass index, smoking status and smoking amount were compared with matched healthy subjects (non-COPD group). Participants taking medications and/or with a history of hypertension, diabetes mellitus, dyslipidaemia, COPD or cardiovascular disease were excluded.
RESULTS: A total of 126 patients (COPD group 42, non-COPD group 84) were enrolled. The IMT and hsCRP of the COPD group were significantly higher than in the non-COPD group (P < 0.05). The decrease in the forced expiratory volume in 1 second/forced vital capacity (FEV(1)/FVC) ratio and FEV(1) was significantly correlated with an increase in the hsCRP and IMT (P < 0.05); there was no correlation between the IMT and hsCRP (P = 0.152).
CONCLUSION: In newly diagnosed untreated patients with COPD, the carotid artery IMT and hsCRP were significantly higher than in healthy subjects. These findings suggest that systemic inflammation may play a potential role in preclinical atherosclerosis in COPD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21943856     DOI: 10.5588/ijtld.10.0680

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

1.  Three-dimensional ultrasound measurements of carotid vessel wall and plaque thickness and their relationship with pulmonary abnormalities in ex-smokers without airflow limitation.

Authors:  Jieyu Cheng; Damien Pike; Tommy W S Chow; Miranda Kirby; Grace Parraga; Bernard Chiu
Journal:  Int J Cardiovasc Imaging       Date:  2016-06-24       Impact factor: 2.357

2.  Relationship between FEV1 and Cardiovascular Risk Factors in General Population without Airflow Limitation.

Authors:  Jeong Hyeon Lee; Yun-Seong Kang; Yun-Jeong Jeong; Young-Soon Yoon; Won Gun Kwack; Jin Young Oh
Journal:  Can Respir J       Date:  2016-11-28       Impact factor: 2.409

3.  Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2).

Authors:  Vijay Kunadian; Danny Chan; Hani Ali; Nina Wilkinson; Nicola Howe; Elaine McColl; Jared Thornton; Alexander von Wilamowitz-Moellendorff; Eva-Maria Holstein; Graham Burns; Andrew Fisher; Deborah Stocken; Anthony De Soyza
Journal:  BMJ Open       Date:  2018-05-26       Impact factor: 2.692

4.  Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort.

Authors:  Surya P Bhatt; Hrudaya P Nath; Young-Il Kim; Rekha Ramachandran; Jubal R Watts; Nina L J Terry; Sushil Sonavane; Swati P Deshmane; Prescott G Woodruff; Elizabeth C Oelsner; Sandeep Bodduluri; MeiLan K Han; Wassim W Labaki; J Michael Wells; Fernando J Martinez; R Graham Barr; Mark T Dransfield
Journal:  Respir Res       Date:  2018-12-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.